echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Two drugs from China Resources Double-Crane's wholly-owned subsidiaries obtained "Drug Registration Certificate"

    Two drugs from China Resources Double-Crane's wholly-owned subsidiaries obtained "Drug Registration Certificate"

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 1, China Resources Double-Crane issued an announcement stating that its wholly-owned subsidiary, China Resources SECCO, had recently received amlodipine and atorvastatin calcium tablets and sildenafil citrate tablets from the National Food and Drug Administration.
    Registration Certificate" to approve the production of these drugs
    .

    Amlodipine and atorvastatin calcium tablets are suitable for patients who require amlodipine and atorvastatin combination therapy
    .


    Among them, amlodipine is used for the treatment of hypertension, chronic stable angina, vasospasm angina (Prinzmetal's or variant angina), and coronary heart disease confirmed by angiography; atorvastatin is used for high cholesterol blood And treatment of coronary heart disease


    Sildenafil citrate tablets are suitable for the treatment of erectile dysfunction


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.